Lung cancer patients undergoing noninvasive positive pressure ventilation (NIPPV) have high mortality rates predicted by progressive disease or newly diagnosed lung cancer and organ failure, a recent study has shown.
Dermoscopy plus conventional and modified clinical ABCD criteria (amelanotic, bleeding bump, colour uniformity, de novo at any diameter) improves diagnosis of paediatric melanoma (PM), suggests a recent study. Dermoscopy helps in differentiating spitzoid from nonspitzoid melanomas.
Nonmuscle invasive bladder cancer (NIBC) has recurred in one in four patients following a complete response to trimodality therapy, with some of them experiencing recurrence more than a decade after trimodality therapy, a recent study has shown. There are no baseline clinicopathological characteristics associated with such recurrence after a complete response.
Renal cancer surgery-related glomerular filtration rate (GFR) loss, whether due to partial or radical nephrectomy, affects the risk of chronic kidney disease (CKD) but may have less impact on survival, reports a recent study.
Elevated serum levels of brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) appear to signal tumour progression, as well as subclinical functional and structural myocardial damage, in patients with advanced renal cell carcinoma (RCC), according to a study.
Future development of distant metastases can be accurately predicted by combining primary tumour and stromal features with the histopathological patterns of involved and uninvolved lymph nodes (LN), a recent study has found.
Use of NC-6004, a novel cisplatin nanoparticle developed using micellar technology, as an adjunct to gemcitabine in the treatment of patients with advanced solid tumours appears to be well tolerated, and greater equivalent doses of cisplatin are achieved with no clinically significant neurotoxicity, ototoxicity or nephrotoxicity, as shown in a recent study.
A 55-year-old man presented with almost one year history of heat intolerance, mild palpitation and significant weight loss. Free T3 and T4 were elevated with normal TSH. Patient had suboptimal response to carbimazole therapy.
Elvira Manzano, Roshini Claire Anthony,
2 days ago
Osimertinib significantly improved progression-free survival (PFS) over standard first-line therapy in the phase III FLAURA trial and experts say it could be the next standard of care (SoC) for advanced non-small cell lung cancer (NSCLC) harbouringEGFR mutation (EGFRm).